Author:
La Rochelle Pierre,Lexchin Joel,Simonyan David
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference100 articles.
1. Guyatt G, Oxman A, Sultan S, Glasziou P, Akl E, Alonso-Coello P, et al. GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol. 2011;64:1311–6.
2. Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberati A, et al. Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence (Background Document). Oxford Centre for Evidence-Based Medicine; 2011. http://www.cebm.net/index.aspx?o=5653 . Accessed 16 Aug 2016.
3. Darrow J, Kesselheim A. Drug development and FDA approval. N Engl J Med. 2014;370:e39.
4. Junod S. FDA and clinical drug trials: a short history: US Food and Drug Administration; 2016. http://www.fda.gov/AboutFDA/WhatWeDo/History/Overviews/ucm304485.htm . Accessed 25 Aug 2016.
5. Graham D, Campen D, Hui R, Spence M, Cheetham C, Levy G, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet. 2005;365:475–81.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献